HAEMONETICS CORP MASS - NOTE 3/0

Historical Holders from Q1 2022 to Q3 2025

Type / Class
Debt / NOTE 3/0
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
299,324,000
Holdings value
$293,438,296
% of all portfolios
0%
Number of holders
42
Number of buys
16
Number of sells
-11
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of HAEMONETICS CORP MASS - NOTE 3/0

Period Principal Value Change Price Investors
2025 Q3 299,324,000 $293,438,296 +$2,098,325 $0.9776 42
2025 Q2 297,562,000 $287,850,876 +$2,025,392 $0.965 43
2025 Q1 295,109,639 $282,286,333 +$2,783,545 $0.9544 44
2024 Q4 292,307,277 $275,910,787 -$9,147,417 $0.9413 45
2024 Q3 303,732,277 $281,293,777 -$18,502,186 $0.925 51
2024 Q2 324,676,273 $293,289,879 -$199,609,301 $0.9015 47
2024 Q1 538,925,331 $502,061,838 -$13,353,742,550 $0.9196 49
2023 Q4 495,645,344 $442,147,642 +$20,282,323 $0.8905 47
2023 Q3 471,885,170 $412,030,565 +$3,879,149 $0.8683 51
2023 Q2 467,571,318 $401,252,073 -$2,136,061 $0.8544 51
2023 Q1 468,923,009 $399,453,244 +$26,559,166 $0.8505 46
2022 Q4 438,307,098 $364,276,052 -$4,237,742 $0.8313 48
2022 Q3 442,309,775 $354,988,164 -$3,162,666 $0.8 51
2022 Q2 446,562,359 $352,231,878 +$21,406,997 $0.7876 43
2022 Q1 438,877,655 $370,775,206 +$370,775,196 $0.8421 35